212 related articles for article (PubMed ID: 8546123)
1. Lipoprotein(a) in renal disease.
Kronenberg F; Utermann G; Dieplinger H
Am J Kidney Dis; 1996 Jan; 27(1):1-25. PubMed ID: 8546123
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) in health and disease.
Kronenberg F; Steinmetz A; Kostner GM; Dieplinger H
Crit Rev Clin Lab Sci; 1996; 33(6):495-543. PubMed ID: 8989507
[TBL] [Abstract][Full Text] [Related]
3. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
Dieplinger H; Kronenberg F
Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.
Kronenberg F; König P; Lhotta K; Ofner D; Sandholzer C; Margreiter R; Dosch E; Utermann G; Dieplinger H
Arterioscler Thromb; 1994 Sep; 14(9):1399-404. PubMed ID: 8068599
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
[TBL] [Abstract][Full Text] [Related]
9. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
Kimak E; Solski J
Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
[TBL] [Abstract][Full Text] [Related]
10. LDL-unbound apolipoprotein(a) and carotid atherosclerosis in hemodialysis patients.
Kronenberg F; Trenkwalder E; Sturm W; Kathrein H; König P; Neyer U; Gröchenig E; Utermann G; Dieplinger H
Clin Genet; 1997 Nov; 52(5):377-86. PubMed ID: 9520130
[TBL] [Abstract][Full Text] [Related]
11. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease.
Kim SB; Yang WS; Kang ES; Min WK; Park JS
Perit Dial Int; 1997; 17(3):236-42. PubMed ID: 9237283
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.
Trenkwalder E; Gruber A; König P; Dieplinger H; Kronenberg F
Kidney Int; 1997 Dec; 52(6):1685-92. PubMed ID: 9407518
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein(a) in chronic renal disease.
Stenvinkel P; Berglund L
Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
[TBL] [Abstract][Full Text] [Related]
17. Apo(a) phenotypes and lp(a) concentrations in renal transplant patients.
Kandoussi AM; Hugue V; Cachera C; Hazzan M; Dracon M; Tacquet A; Noël C
Nephron; 1998 Oct; 80(2):183-7. PubMed ID: 9736817
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.
Kronenberg F; Kathrein H; König P; Neyer U; Sturm W; Lhotta K; Gröchenig E; Utermann G; Dieplinger H
Arterioscler Thromb; 1994 Sep; 14(9):1405-11. PubMed ID: 8068600
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.
Kerschdorfer L; König P; Neyer U; Bösmüller C; Lhotta K; Auinger M; Hohenegger M; Riegler P; Margreiter R; Utermann G; Dieplinger H; Kronenberg F
Atherosclerosis; 1999 Jun; 144(2):381-91. PubMed ID: 10407499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
